Isoniazid
Isoniazid is a pharmaceutical drug with 89 clinical trials. Currently 8 active trials ongoing. Historical success rate of 85.5%.
Success Metrics
Based on 53 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
26
Mid Stage
30
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.5%
53 of 62 finished
14.5%
9 ended early
8
trials recruiting
89
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Shortened Regimen for Drug-susceptible TB in Children
Tuberculosis Clinical Trials Consortium Study 35
A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis
Clinical Trials (89)
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Shortened Regimen for Drug-susceptible TB in Children
Tuberculosis Clinical Trials Consortium Study 35
A Phase I Study Investigating the Local Tolerability and Pharmacokinetics of Isoniazid (INH) Inhalation by Wet Nebulization in Patients With Tuberculosis
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection
Re-evaluating the Duration in Children of TB Treatment
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
PanACEA - STEP2C -01
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 89